Hip arthroplasty in haemodialysis patients.

Hip arthroplasty in haemodialysis patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Hip arthroplasty in haemodialysis patients. Abstract Text:

M Naito,K Ogata,E Shiota,M Nakamoto,T Goya,

We retrospectively reviewed 17 hip arthroplasties in 15 patients having haemodialysis for chronic renal failure. The duration of haemodialysis before the operation averaged 8.6 years and the average age of the patients was 61 years. All patients were followed for more than two years (mean 4.6 years). Six arthroplasties in four patients had failed due to loosening, and one of these patients died from undiagnosed infection of both hips at 7.6 years after the operation. General skeletal abnormalities caused by maintenance haemodialysis may explain the high incidence of loosening and it is important to be aware of the danger of postoperative infection. The risk-to-benefit ratio of hip arthroplasty is high in patients on haemodialysis.

Hip arthroplasty in haemodialysis patients. Publishing Authors By Initials

M Naito,K Ogata,E Shiota,M Nakamoto,T Goya,

For similar investigative techniques: epidemiologic methods: epidemiologic study characteristics as topic: epidemiologic studies: case-control studies: retrospective studies research abstracts see: investigative techniques: epidemiologic methods: epidemiologic study characteristics as topic: epidemiologic studies: case-control studies: retrospective studies research

PUBMED ID PMID:

MEDLINE DATE:

Hip arthroplasty in haemodialysis patients. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of bone and joint surgery. British vol

VOLUME: 76

Page Numbers: 428-31

Journal Abbreviation:

ISSN: 0301-620X

DAY: 14

MONTH: May

YEAR: 1994

Hip arthroplasty in haemodialysis patients. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 375355

Hip arthroplasty in haemodialysis patients. Keywords Mesh Terms:

KEYWORDS: Retrospective Studies

MESH TERMS: adverse effects

Chemical & Substance for Abstract: Hip arthroplasty in haemodialysis patients. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Hip arthroplasty in haemodialysis patients.

AFFILIATION: Department of Orthopaedic Surgery, Fukuoka University School of Medicine, Japan.

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Bone Joint Surg Br

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Hip arthroplasty in haemodialysis patients Related Publications

• A malignant peripheral nerve sheath tumor of the mediastinum in a patient with neurofibromatosis type 1: Report of a case.
• CB1 cannabinoid antagonists: structure-activity relationships and potential therapeutic applications.
• Differential diagnosis of primary versus metastatic pulmonary adenocarcinomas using gene mutation analyses: a case report.
• Fatty acid profiles in hepatic membranes of rats with different levels of circulating estrogen and prolactin.
• Gene therapy for long-term restoration of circulating thymulin in thymectomized mice and rats.
• Hip arthroplasty in haemodialysis patients.
• Insulin-like growth factor-I gene therapy reverses morphologic changes and reduces hyperprolactinemia in experimental rat prolactinomas.
• Loss of NeuN immunoreactivity in rat spinal cord neurons during aging.
• Novel method for bulla detection with video-assisted thoracoscopic surgery in patients with spontaneous pneumothorax.
• Partial anomalous pulmonary venous connection in right lung cancer: Report of a case.
• Partial prevention of hepatic lipid alterations in nude mice by neonatal thymulin gene therapy.
• Potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models.
• Protection of Human HepG2 Cells against Oxidative Stress by Cocoa Phenolic Extract.
• Restorative effect of insulin-like growth factor-I gene therapy in the hypothalamus of senile rats with dopaminergic dysfunction.
• Selenium methylselenocysteine protects human hepatoma HepG2 cells against oxidative stress induced by tert-butyl hydroperoxide.
• Studies of tetralin derivatives. II. Ultraviolet spectra of hydroxytetralins and hydroxytetralons.